Skip to content

OptimizeRx OPRX Shares (Diluted)

Discontinued — last reported Q1 '26

Shares (Diluted) at other companies

Veeva Systems logo
Veeva SystemsVEEV
166M-0.1%
Phreesia logo
PhreesiaPHR
62M+5.3%
Doximity logo
DoximityDOCS
199M-1.1%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
341.4M-10.1%
PubMatic logo
PubMaticPUBM
47.1M-2.5%
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
31.8M+32.2%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's shares (diluted)?
OptimizeRx (OPRX) reported shares (diluted) of 18.8M in Q1 2026.
How has OptimizeRx's shares (diluted) changed year-over-year?
OptimizeRx's shares (diluted) increased by 1.6% year-over-year, from 18.5M to 18.8M.
What is the long-term trend for OptimizeRx's shares (diluted)?
Over 4 years (2021 to 2025), OptimizeRx's shares (diluted) has grown at a 2.0% compound annual growth rate (CAGR), from 70.1M to 75.9M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.